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Purpose: To review the clinical experience, management and outcome of cervicofacial necro-
tizing  fasciitis (CNF) in patients treated in our institution.
Methods: A retrospective review of patients with CNF from two  large health care institutions
completed over a 10-year period.
Results: Five patients with complete data were identiﬁed. CNF was polymicrobial in 4 and
monomicrobial in one patient and occurred as a result of odontogenic infection in 3, trauma
in  1, and was idiopathic in one patient. All patients were treated with extensive debridement,
broad spectrum antibiotics, and reconstruction with ﬂaps. There was one death.
Conclusions: Early diagnosis and rapid aggressive debridement are key elements for reducing
mortality and optimizing the cosmetic and functional outcome in patients with CNF.
©  2014 SECOM. Published by Elsevier España, S.L.U. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Propósito: Revisar la experiencia clínica, el manejo quirúrgico y los resultados del
tratamiento de pacientes con fasceítis necrosante cervicofacial (FNC) en nuestras institu-
ciones.
Métodos: Un estudio retrospectivo de pacientes con FNC en un periodo de 10 an˜os en 2
instituciones académicas.
Resultados: Cinco pacientes con datos completos (clínicos, imágenes, cultivos microbiológi-
cos,  tratamiento y seguimiento) fueron identiﬁcados. La FNC resultó de una infección
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polimicrobiana en 4 pacientes y monomicrobiana en un paciente. La etiología de FNC fue
odontogénica en 3 pacientes, postraumatismo en un paciente e idiopática en un paciente.
Todos los pacientes fueron tratados con tratamiento quirúrgico (desbridamiento) agresivo
temprano, antibióticos de amplio espectro y reconstrucción con diferentes tipos de colgajos.
Se  registró una mortalidad.
Conclusiones: El diagnóstico temprano y un tratamiento quirúrgico agresivo son elementos
clave en reducir la mortalidad y optimizar los resultados funcionales y cosméticos en los
pacientes con FNC.
© 2014 SECOM. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access
bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Necrotizing fasciitis (NF) is an uncommon soft tissue infection
that results in the rapid and progressive necrosis of the con-
nective tissue and muscle fascia. In more  advanced stages,
it involves the skin and muscle, and the mortality rate is
high. Cervicofacial NF (CNF) is a rare condition that consti-
tutes between 2.6% and 5% of all the cases of FN.1,2 It is not
common for any one center to gather signiﬁcant clinical expe-
rience with CNF.
There are many  historical accounts of and references to
NF that date back to Hippocrates (500 BC), who  reported dif-
fuse lesions that would not heal. Pouteau and Gillespie, in
1783 and 1785, respectively, described malignant, gangrenous
ulcers.3 In 1871, Joseph Jones, who  had been a Confederate
surgeon in the United States Civil War, was the ﬁrst to offer a
precise description of NF, which he referred to as “hospital
gangrene”.4 Meleney reported 20 cases of hemolytic strep-
tococcal gangrene in 19245 and, in 1952, Wilson used the
term necrotizing fasciitis for the ﬁrst time.6 The information
on the presentation, management and results of the treat-
ment of patients with NF in the head and neck region is
limited.
Necrotizing fasciitis is classiﬁed according to 3 differ-
ent types, depending on the microbiological ﬁndings. Type
1 is a polymicrobial infection produced by a combination
of anaerobic and aerobic bacteria, whereas type 2 is a
monomicrobial infection due mainly to group A -hemolytic
streptococcus and, less frequently, to other streptococci and
staphylococci; type 3 is a monomicrobial infection caused
by a marine Vibrio species.7 The clinical signs of NF include
swelling, erythema, pain, skin blistering and crepitus.8 The
purpose of this article is to review our experience and
report the demographic data, treatment microbiological ﬁnd-
ings and reconstruction carried out in 5 patients with
CNF.
Materials  and  methods
We  carried out a retrospective review of the cases of CNF
treated between December 2002 and December 2012 in the
oral and maxillofacial surgery units of 2 centers (MetroHealth
Medical Center [MHC] in Cleveland, Ohio, United States, and
the Instituto de Medicina Tropical Alexander von Humboldt
[IMT] of the Universidad Peruana Cayetano Heredia in Lima,
Peru). A total of 590 moderate and severe maxillofacial infec-
tions were identiﬁed, 7 of which (1.19%) were diagnosed as
CNF. At the MHC, we  identiﬁed 332 infections with 4 cases
(1.2%) of CNF, and the IMC  reported 258 cases, including 3
(1.16%) of CNF. Moderate maxillofacial infections were con-
sidered to be those that involved one or more  of the following
fascial spaces: submandibular, submental, sublingual, ptery-
gomandibular, superﬁcial temporal and deep temporal. Severe
maxillofacial infections were deﬁned as any infection that
required in-hospital management and/or threatened to com-
promise the lateral pharyngeal, retropharyngeal, pretracheal
and danger spaces, as well as mediastinal and intracranial
infections.9
Results
Seven patients with CNF were identiﬁed on the basis of the
data provided by the centers in which the present study was
conducted. Two patients were excluded because of insufﬁ-
cient clinical data and a lack of follow-up. All of the patients
were adults of the male sex, with ages between 30 and 61
years. Three patients were black, one was mestizo and another
was white. All of them presented with severe pain, erythema,
swelling, necrosis and subcutaneous gas. The clinical pho-
tographs can be seen in Figs. 1 and 2.
The demographic and bacteriological data, location and
type of reconstruction carried out are summarized in Table 1.
Two patients had systemic comorbidities: patient no. 3 had
morbid obesity and patient no. 4 had type 1 diabetes mel-
litus and hypertension. The only death in our case series
was that of a patient involved in a trafﬁc accident as
a pedestrian, who had multiple injuries (facial and rib
fractures) and an in-hospital course complicated by pro-
longed ventilatory support and multiple respiratory tract
infections.
Figs. 3 and 4 show the defects in the 5 reported patients.
Patient no. 1 underwent reconstruction with a skin graft.
In patient no. 2, an advancement ﬂap was created. Patient
no. 3 underwent supraclavicular ﬂap creation. The defect
in patient no. 4 was closed by means of an advance-
ment ﬂap. Patient no. 5 underwent repair with a submental
artery island ﬂap which, unfortunately, failed; the defect
subsequently healed by second intention, leaving a conspic-
uous scar; the patient refused to undergo revision of the
scar.
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Table 1 – Demographic and clinical characteristics of the patients and treatment of cervicofacial necrotizing fasciitis in each.
Case/age/G/R Site Bacteriology Initial presentation Initial white
blood cell count
Antibiotic therapy Reconstruction Outcome
1/61/M/MR Submandibular,
right lateral
neck
Proteus mirabilis Swelling, pain, erythema
and skin discoloration
(black), skin blistering,
subcutaneous gas, pus
24,600 Ceftazidime,
ciproﬂoxacin,
clindamycin
Partial-
thickness
skin  graft
Survival
2/30/M/B Submental Prevotella spp., Clostridium difﬁcile,
Peptostreptococcus micros,
Streptococcus milleri, Streptococcus
intermedius, Coagulase-negative
Staphylococcus spp., Candida
albicans
Swelling, pain, erythema
and skin discoloration
(grayish), skin blistering,
subcutaneous gas, pus
25,400 Vancomycin,
piperacillin/tazobactam,
ertapenem
Advancement
ﬂap
Survival
3/60/M/W Sub mental,
chin
Streptococcus intermedius,  Prevotella
corporis, Bacteroides fragilis,
Staphylococcus spp., Gemella
morbillorum, Streptococcus
constellatus,  Prevotella
melaninogenica,  Prevotella oris
Swelling, pain, erythema
and skin discoloration
(black), skin blistering,
subcutaneous gas, pus
10,900 Ampicillin/sulbactam,
vancomycin
Supraclavicular
ﬂap
Survival
4/56/M/B Submandibular,
right lateral
neck
Prevotella buccae, Prevotella
intermedia, Peptostreptococcus
asaccharolyticus, Bacillus species,
Streptococcus constellatus,
Saprophytic Neisseria species,
Eikenella species, -hemolytic
streptococcus, not enterococcus or
pneumococcus, anaerobic
Gram + cocci
Swelling, pain, fever,
erythema, pus
13,700 Ampicillin/sulbactam,
vancomycin,
piperacillin/tazobactam
Advancement
ﬂap
Death
5/39/M/B Right cheek Pseudomonas aeruginosa,
Streptococcus gordonii,  Klebsiella
pneumoniae, Bacteroides capillosus
Swelling, pain, pus, skin
discoloration
25,400 Ampicillin/sulbactam,
vancomycin
Submental
artery island
ﬂap
Survival
B: black; G: gender; M: male; MR: mixed race; R: race; W:  white.
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Patient no. 1 Patient no. 2 Patient no. 3
Patient no. 5Patient no. 4
Fig. 1 – The initial clinical characteristics of our patients with cervicofacial necrotizing fasciitis.
Discussion
Necrotizing fasciitis is a serious infection associated with a
mortality rate that can reach approximately 30%.10 The most
important factors in the reduction of the mortality are early
diagnosis and early aggressive surgical treatment. The key
ﬁndings that lead to a correct diagnosis are a combination of
the clinical presentation (pain, which generally is severe and
disproportionate with respect to the physical ﬁndings, ery-
thema, swelling and induration, tenderness to touch beyond
the region of erythema, subcutaneous crepitus, skin blister-
ing and skin discoloration).11,12 The radiographic signs include
gas in soft tissues, very often associated with ﬂuid collec-
tion in the connective tissue and cervical fascia. Reactive
lymphadenopathy can also be observed.13,14 The microbiolog-
ical studies performed in our patients revealed polymicrobial
infections in 4 and monomicrobial infection in 1 (patient no.
1), in whom only Proteus mirabilis was isolated. Streptococci
and staphylococci were the predominant aerobic bacteria. The
majority of the anaerobic bacteria isolated were peptostrepto-
cocci and Prevotella species.
McHenry et al. reported 65 patients with necrotizing soft
tissue infections and only 2 (3%) were found in head and neck,
whereas 37 (57%) were located in trunk and 26 (40%) in extrem-
ities. The mortality rate was  29%; the 2 patients with CNF
survived. In their series, McHenry et al. found a number of
factors that had a signiﬁcant impact on the outcome, includ-
ing time from hospital admission to operation, percentage of
body surface area involved, acidosis, peripheral vascular dis-
ease, the number of systemic diseases and age. When the
factors were correlated with mortality, the only statistically
signiﬁcant factor was  a prolonged time between admission
and surgical treatment.13 This ﬁnding has also been reported
Patient no. 2 Patient no. 3
38.0 mm
3D: 41.4 mm
3D: 48.5 mm
Fig. 2 – Examples of computed tomography slices and 3D reconstruction.
r e v  e s p  c i r  o r a l  m a x i l o f a c .  2016;38(1):29–34 33
Fig. 3 – Different defects after aggressive debridement.
Patient no. 1. Twenty weeks after
undergoing skin graft.
Patient no. 3. Six weeks after
undergoing supraclavicular flap..
Patient no. 5. Scar left 8 weeks after
healing by second intention.
Fig. 4 – Examples of the outcome of surgical treatment in patients 1, 3 and 5.
by other authors.15–18 In our study, the rate of mortality was
20%, which is similar to or slightly lower than those observed
by other authors.10,19–22 In patient no. 4 of our series, there
was a delay in the identiﬁcation of a postoperative infection.
The surgical wound was edematous, but showed no signs of
skin necrosis. This delay in the identiﬁcation of the infection
may have contributed to his death, although it most probably
was multifactorial, related to multiple comorbidities, injuries,
hospital-acquired pneumonia and respiratory failure.
Owing to the fact that early aggressive surgical treatment is
the key factor for survival, CNF should be suspected in patients
with erythema and induration of the skin, severe pain that is
disproportionate with respect to the physical ﬁndings, tender-
ness to the touch in areas free of erythema, rapid progression
and hemodynamic instability, although the most important
clinical signs of this disease are crepitus, blistering and skin
necrosis.
Cervicofacial NF is commonly secondary to an odontogenic
infection, and is less often found to be secondary to trauma-
tism. On rare occasions, no etiological factor or obvious portal
of entry for the bacteria is identiﬁed, as occurred in patient no.
1 of our series. This spontaneous presentation of NF has been
reported in up to 20% of the patients.18
Conclusion
Cervicofacial NF is a rare infection associated with high rates
of morbidity and mortality. Early diagnosis and rapid and
aggressive surgical treatment can reduce these rates.
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